GlassScriptPhysician profile
Stacie Diette
NPI 1033629118
$1,183.55
in general payments reported to CMS, 2019-2025
15 companies · $573 in 2025
The $573 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.98 · 2022: $70.58 · 2023: $212 · 2024: $313 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $238.17 | 2023-2025 | |
| Biogen, INC. | $214.49 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $189.01 | 2023-2025 | |
| Novo Nordisk INC | $124.99 | 2024 | Wegovy |
| Evofem Biosciences, INC. | $83.44 | 2024-2025 | Solosec, Phexx, Phexxi |
| Astellas Pharma US INC | $59.47 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $55.66 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Mylan Pharmaceuticals INC. | $39.85 | 2022 | |
| Lilly USA, LLC | $35.18 | 2025 | Mounjaro, Zepbound |
| Organon LLC | $33.97 | 2025 | Jada System |
| Abbvie INC. | $30.63 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $25.00 | 2024 | |
| Sumitomo Pharma America, INC. | $24.55 | 2025 | Myfembree |
| Avion Pharmaceuticals | $14.72 | 2023 | Balcoltra |
| Coopersurgical, INC. | $14.42 | 2025 | Endosee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacie Diette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.